Elisa Hebb
Chief Tech/Sci/R&D Officer at ENDOLOGIX, INC.
Profile
Elisa Hebb is currently the EVP-Clinical Development & Regulatory Affairs at Endologix LLC since 2018.
Prior to this, she held the position of Vice President-Clinical & Regulatory Affairs at Crux Biomedical, Inc. starting in 2008 and Vice President-Clinical Affairs at Apneon, Inc. starting in 2007.
Ms. Hebb's former positions include Director-Clinical Programs at Boston Scientific Corp., Senior Director-Global Clinical Affairs at Philips Image Guided Therapy Corp.
from 2014 to 2015, and Senior Director-Clinical Affairs at Wallace Enterprises, Inc. Ms. Hebb completed her undergraduate degree at the University of California, Berkeley.
Elisa Hebb active positions
Companies | Position | Start |
---|---|---|
ENDOLOGIX, INC. | Chief Tech/Sci/R&D Officer | 2018-07-31 |
Apneon, Inc.
Apneon, Inc. Medical SpecialtiesHealth Technology Founded in 2003 by Dr. Lionel Nelson and Eric Doelling, Apneon is dedicated to developing innovative solutions for treating obstructive sleep apnea (OSA) - the cessation of breathing during sleep. OSA is a serious and life-threatening condition that plagues millions of Americans and is most commonly recognized by excessive daytime sleepiness. Even with current treatments, sleep apnea is associated with significantly increased risk of stroke and death. Current treatment methods tend to be poorly tolerated, and/or of limited efficacy. Apneon is developing a unique and inventive approach intended to provide an effective treatment for OSA. | Chief Tech/Sci/R&D Officer | 2007-09-30 |
Crux Biomedical, Inc.
Crux Biomedical, Inc. Medical SpecialtiesHealth Technology Crux Biomedical, Inc. develops and manufactures medical devices. The company was founded by Thomas Fogarty and Frank Arko in August 2004 and is headquartered in San Diego, CA. | General Counsel | 2009-11-02 |
Former positions of Elisa Hebb
Companies | Position | End |
---|---|---|
VOLCANO CORPORATION | Chief Tech/Sci/R&D Officer | 2015-11-30 |
BOSTON SCIENTIFIC CORPORATION | Corporate Officer/Principal | - |
Wallace Enterprises, Inc.
Wallace Enterprises, Inc. Medical SpecialtiesHealth Technology Wallace Enterprises, Inc. develops, manufactures and markets devices for treating peripheral vascular disease and nonvascular obstructions. The company was founded by Thomas J. Fogarty in 1997 and is headquartered in Nashville, TN. | Chief Tech/Sci/R&D Officer | - |
Training of Elisa Hebb
University of California, Berkeley | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
BOSTON SCIENTIFIC CORPORATION | Distribution Services |
Private companies | 5 |
---|---|
Endologix LLC
Endologix LLC Medical SpecialtiesHealth Technology Endologix LLC engages in the research, development, manufacture, and trade of medical devices for the treatment of aortic disorders such as abdominal aortic aneurysms (AAA). Its products include AFX Endovascular AAA System, Nellix and Ovation. The company was founded in March 1992 and is headquartered in Irvine, CA. | Health Technology |
Philips Image Guided Therapy Corp.
Philips Image Guided Therapy Corp. Medical SpecialtiesHealth Technology Volcano Corp. designs, develops and manufactures a broad suite of intravascular ultrasound products. The company was founded by Olav B. Bergheim and Samuel Ward Casscells and is headquartered in San Diego, CA. | Health Technology |
Crux Biomedical, Inc.
Crux Biomedical, Inc. Medical SpecialtiesHealth Technology Crux Biomedical, Inc. develops and manufactures medical devices. The company was founded by Thomas Fogarty and Frank Arko in August 2004 and is headquartered in San Diego, CA. | Health Technology |
Apneon, Inc.
Apneon, Inc. Medical SpecialtiesHealth Technology Founded in 2003 by Dr. Lionel Nelson and Eric Doelling, Apneon is dedicated to developing innovative solutions for treating obstructive sleep apnea (OSA) - the cessation of breathing during sleep. OSA is a serious and life-threatening condition that plagues millions of Americans and is most commonly recognized by excessive daytime sleepiness. Even with current treatments, sleep apnea is associated with significantly increased risk of stroke and death. Current treatment methods tend to be poorly tolerated, and/or of limited efficacy. Apneon is developing a unique and inventive approach intended to provide an effective treatment for OSA. | Health Technology |
Wallace Enterprises, Inc.
Wallace Enterprises, Inc. Medical SpecialtiesHealth Technology Wallace Enterprises, Inc. develops, manufactures and markets devices for treating peripheral vascular disease and nonvascular obstructions. The company was founded by Thomas J. Fogarty in 1997 and is headquartered in Nashville, TN. | Health Technology |
- Stock Market
- Insiders
- Elisa Hebb